1B rheumatoid arthritis and other inflammatory diseases Flashcards

1
Q

What is arthritis?

A

Disease of the joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two major divisions of arthritis?

A
  • Osteoarthritis (degenerative)
  • Arthritis with signs of inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some clinical examination signs of joint inflammation?

A
  • Red
  • Hot/warm
  • Swelling/fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the causes of joint inflammation?

A

1) Infection: Septic arthritis, TB
2) Crystal arthritis: Gout, Pseudogout
3) Immune-mediated (autoimmune)

Infection and crystal arthritis are secondary inflammations in response to a noxious insult.

Immune-mediated arthritis is referred to as ‘primary inflammation’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the distinguishing features of the different types of arthritis?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is septic arthritis?

A

An orthopaedic emergency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical features of septic arthritis?

A

Acute hot, swollen joint = SEPTIC ARTHRITIS until proven otherwise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the key investigations for septic arthritis?

A
  • Joint aspiration
  • Send fluid for Gram stain and culture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management for septic arthritis?

A
  • Joint lavage
  • IV antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is rheumatoid arthritis?

A

A chronic autoimmune disease causing synovial inflammation (synovitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is the primary site of pathology of RA?

A

Synovium found at:

  • Synovial (diarthrodial) joints
  • Tenosynovium surrounding tendons
  • Bursa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does this show?

A

Proximal inter-phalangeal joint synovitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does this show?

A

Extensor tensoynovitis: swelling is not above either the wrist or MCP joints

The patient has incomplete extension of the little and ring fingers (cannot stick the fingers out straight)- this is consistent with extensor tendon damage by the tenosynovitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does this show?

A

Olecranon bursitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the age of onset for RA?

A

30-50s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the key features of RA?

A
  • Chronic arthritis:
    • polyarthritis
    • pain, swelling and early MORNING STIFFNESS in and around joints
    • may lead to joint damage and destruction: ‘joint erosions’ on radiographs
  • Systemic disease with extra-articular manifestations
  • Auto-antibodies usually detected in blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the aetiology of RA

A

There is a mixture of genetic and environmental impact.

Environmental factors include:
- Smoking
- Microbiome
- Porphyromonas gingivalis
- Poor oral health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is ACPA?

A

Anti-citrullinated protein antibodies (ACPA)

Smoking causes citrullination of proteins in lung epithelium. P. gingivalis can also cause citrullination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the strongest genetic risk factor for RA?

A

HLA-DR

HLA-DRb chain amino acids 70-74 (‘shared epitope’). Smoking & shared epitope synergistically increase risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What other genetic factors other than HLA-DR are there for RA?

A
  • 100 other genetic loci that contribute to RA risk (polygenic), e.g. PTPN22, IL6R
  • Effect of a risk allele at any given locus typically modest
  • Cumulative genetic burden rather than any one variant determines risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is a GWAS done?

A
  • Compare allelic frequencies at a given genetic single nucleotide polymorphism (SNP) between cases vs controls
  • Repeat across the genomes for millions of SNPs
  • Identify the SNPs associated with disease risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the implications of HLA genetic associations?

A

HLA class 1 association (eg HLA-B27 in Ankylosing spondylitis) implicates CD8 T cells in pathogenesis
HLA class 2 association (HLA-DR4 in RA) implicates CD4 T cells and B cells

This fits with autoantibodies (made by B cells) in RA but not in Ank Spond

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the pattern joint involvement in RA

A
  • Symmetrical
  • Affects multiple joints (polyarthritis)
  • Can affect both small and large joints, but nearly always small joints involved
    • particularly hands and feet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the most commonly affected joints in RA?

A
  • Metacarpophalangeal joints (MCP)
  • Proximal interphalangeal joints (PIP)
  • Wrists
  • Knees
  • Ankles
  • Metatarsophalangeal joints (MTP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the difference in presentation in hands between RA and OA

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are systemic extra-articular features of RA?

A
  • Fatigue (v common)
  • Fever
  • Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are organ-specific extra-articular features of RA?

A
  • Subcutaneous nodules
  • Lung disease – nodules, interstitial lung disease (ILD)/ fibrosis, pleuritis
  • Ocular inflammation e.g. episcleritis
  • Vasculitis
  • Neuropathies
  • Felty’s syndrome – triad of splenomegaly, leukopenia and rheumatoid arthritis
  • Amyloidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are subcutaneous nodules?

A

Central area of fibrinoid necrosis surrounded by histiocytes and peripheral layer of connective tissue.

Occur in ~30% patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are subcutaneous nodules associated with?

A
  • Severe disease
  • Extra-articular manifestations
  • Rheumatoid factor
30
Q

What does this show?

A

Rheumatoid nodules in the hands – another common location and not easily missed. Here you can see them around the PIP joint of the right index and left index, middle and ring fingers

31
Q

What does this show?

A

Rheumatoid nodule – this is typical position (ulnar border of forearm) where you might detect nodules. If they are present it confirms the diagnosis of rheumatoid arthritis and is invariably associated with rheumatoid factor. Do not forget to examine this area carefully in patients with polyarthritis – it would be foolish to miss such an important clinical finding

32
Q

Describe the histopathology of a healthy synovial membrane

A

1-3 cell layer that lines synovial joints

Contains:
- macrophage-like (type A synoviocyte)
- fibroblast-like (type B synoviocyte) cells
- type I collagen

33
Q

What is the function of the synovial membrane?

A

Maintenance of synovial fluid

34
Q

Describe the histopathological changes in RA

A

Synovium becomes a proliferated mass of tissue (pannus) due to:

  • Neovascularisation
  • Lymphangiogenesis
    Inflammatory cells:
    • activated B and T cells
    • plasma cells
    • mast cells
    • activated macrophages
35
Q

Describe the pathology of RA and a cellular and molecular level

A
  1. Autoreactive B cells
  2. Autoreactive T cells
  3. Cytokines
    • TNF-alpha
    • IL-6
    • IL-1

XS pro-inflammatory vs anti-inflammatory cytokines (‘cytokine imbalance’)

36
Q

What treatment is given for autoreactive B cells?

A

Rituximab

37
Q

What treatment is given for autoreactive T cells?

A

Abatacept

38
Q

What treatment is given for the cytokines in RA?

A
  • anti-TNF-alpha
  • anti-IL6R
39
Q

What is TNF-alpha?

A

The cytokine tumour necrosis factor-alpha (TNFα) is the dominant pro-inflammatory cytokine in the rheumatoid synovium

40
Q

How does TNF-alpha cause RA?

A

Its pleotropic actions are detrimental in this setting:

  • Inflammatory cell recruitment, angiogenesis, lymphangiogenesis -> Pannus formation
  • Matrix metalloproteases -> Cartilage loss
  • Osteoclast activation -> Bone loss (erosions, osteopenia)
41
Q

What bloods are investigated in RA?

A
  • Inflammatory response
    • ↑ ESR ↑ CRP
  • Sometimes normocytic anaemia
    • ↑PLT
  • Autoantibodies
    • Rheumatoid factor (RF) = antibodies that bind IgG
    • Anti-CCP antibodies
42
Q

Are RFs a good indicator for RA?

A

RF can be positive in other autoimmune and infective conditions, and in individuals without disease.
Therefore, RF positive in the absence of clinical features does not necessarily indicate rheumatoid arthritis

CCP antibodies most specific for rheumatoid arthritis and associated with more aggressive/erosive disease

43
Q

Which antibodies precede symptom onset in RA?

A
  • RF and ACPAs
  • ACPAs predate first clinical symptoms of RA by a median of 4.5 years
44
Q

What imaging is done for RA?

A
  • X-rays: limited to bony structures
  • Ultrasound (US): better for detecting synovitis
  • MRI: can also be used by expensive and time-consuming
45
Q

What are radiographic features of RA?

A
  • Soft tissue swelling
  • Peri-articular osteopenia
  • Bony erosions
    • erosions only occur in established disease. Modern therapy aims to treat EARLY before erosions (permanent damage)
46
Q

What US changes in RA are there?

A
  • Synovial thickening (synovial hypertrophy)
  • Increased blood flow (seen as doppler signal)
  • May defect erosions not seen on plain X-Ray
47
Q

What is the treatment goal of RA?

A

Prevent joint damage

48
Q

What does management of RA require?

A
  • Early recognition of symptoms, referral and diagnosis
  • Prompt initiation of treatment: joint destruction = inflammation x time
  • Aggressive pharmacological treatment to suppress inflammation
49
Q

What pharmacological treatment is given for RA?

A
  • Glucocorticoid therapy (‘steroids’) useful acutely but avoid long-term use because of side-effects.
  • DMARDs’ = disease-modifying anti-rheumatic drugs
    • Immunomodulatory drugs that halt or slow the disease process
50
Q

Give three examples of NSAIDs and explain their relevance in RA management

A

e.g. ibuprofen, naproxen, diclofenac

  • Historically used but increasingly less relevant
  • Can provide partial symptom relief but do not prevent disease progression
  • Unfavourable long-term side-effect profile
51
Q

What is ‘treat to target’?

A

Suppress disease activity to improve outcome

52
Q

How is ‘treat to target’ achieved?

A

Achieved by regular objective measurement of disease activity e.g. DAS28 score

53
Q

What are biological therapies?

A

Proteins (usually Abs) that specifically target a protein

54
Q

Give two biologics for RA targeting cytokines classes and list examples for each

A
  1. Inhibition of tumour necrosis factor-alpha (anti-TNF)
    • antibodies (infliximab, adalimumab, golimumab, certolizumab)
    • fusion proteins (etanercept)
  2. Inhibition of interleukin-6 (IL-6 inhibition) signalling
    • antibodies against IL-6 receptor (tocilizumab; RoActemra)(Sarilumab; Kevzara)
55
Q

Give two biologics targeting lymphocyte classifications and examples of each

A
  1. B-Cell depletion
    • Rituximab: Ab against B cell antigen CD20
  2. Blocking T cell co-stimulation
    • Abatacept: fusion protein- extracellular domain of CTLA-4 linked to modified Fc portion of human immunoglobulin G1
56
Q

How is rituximab given and what does it result in?

A
  • Two IV infusions; 2 weeks apart
  • Results in rapid depletion of peripheral B cells
  • Usually repopulate after ~6-9 months
57
Q

What are side effects of rituximab?

A

Infusion reactions, infection, hypogammaglobulinaemia

58
Q

What is seronegative inflammatory arthritis?

A
  • Family of conditions with overlapping clinical features and pathogenesis
  • Unlike rheumatoid arthritis, RF and CCP antibodies not present in blood (“seronegative”)
    • BUT they are immune-mediated
59
Q

What is psoriasis?

A
  • Psoriasis is an immune-mediated disease affecting the skin
  • Scaly red plaques on extensor surfaces (eg elbows and knees)
  • ~10% of psoriasis patients also have joint inflammation
60
Q

What is the dominant pathogenic pathway of psoriatic arthritis?

A

IL-17, IL-23

61
Q

Describe the relation between skin disease severity and joint manifestations

A

Skin disease severity not correlated to joint manifestations

  • Examine skin carefully for small areas of psoriasis (NB scalp, umbilicus)
  • Sometimes nail changes may be only manifestation
62
Q

Describe clinical presentations of psoriatic arthritis

A

Varied clinical presentations:
- Classically asymmetrical arthritis affecting IPJs
- Enthesitis (inflammation of tendon insertions)

But also can manifest as:
- Spinal and sacroiliac joint inflammation
- Oligoarthritis of large joints
- Arthritis mutilans
- Symmetrical involvement of small joints (rheumatoid pattern)

63
Q

What does this radiograph show?

A

Asymmetrical pattern of joint involvement
Erosions of interphalangeal joints (IPJs)
MCPJs not affected (unlike RA)

64
Q

What does this radiograph show?

A

Dactylitis (‘sausage finger’)
due to enthesitis

65
Q

What is reactive arthritis?

A

Sterile inflammation in joints following infection elsewhere in the body

66
Q

What are common infections of reactive arthritis?

A
  • Urogenital (e.g. Chlamydia trachomatis)
  • GI (e.g. salmonella, shigella, campylobacter)

Reactive arthritis may be first manifestation of HIV or hep C infection

67
Q

What are some important extra-articular manifestations of reactive arthritis?

A
  • Enthesitis (tendon inflammation)
  • Skin inflammation
  • Eye inflammation
68
Q

How long do symptoms show for reactive arthritis?

A
  • Symptoms follow 1-4 weeks after infection and this infection may be mild
  • Reactive arthritis NOT the same as infection in joints (septic arthritis)
69
Q

How do glucocorticoids work?

A
  • Glucocorticoids bind the glucocorticoid receptor (GR)
  • GR resides in cytoplasm
  • On binding by glucocorticoids, steroid-GR complex translocates to the nucleus and binds DNA response elements, affecting transcription
70
Q

How are glucocorticoid steroids administered?

A
  • Oral prednisolone
  • Intramuscular (IM) methyl prednisolone
  • Intravenous (IV)
  • Intra-articular (IA)
71
Q

What are side effects of steroids?

A

Many and bad!
Cushing’s syndrome